Mirae Asset Global ETFs Holdings’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.8K Buy
329
+51
+18% +$674 ﹤0.01% 3151
2026
Q1
$3.83K Buy
+278
New +$4.19K ﹤0.01% 3102

Other funds holding CLBT

Mirae Asset Global ETFs Holdings's CLBT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Cellebrite (CLBT) stake by 18% in Q2 2026, buying an estimated $674 and bringing the position to 329 shares worth $4.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3151.

Mirae Asset Global ETFs Holdings first reported a position in CLBT in Q1 2026 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 329 shares of Cellebrite worth $4.8K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 51 Cellebrite shares in Q2 2026, an estimated $674.
  • Cellebrite made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #3151 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Cellebrite in Q1 2026 and has held it in 2 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.